Published in Women's Health Weekly, August 11th, 2011
"The aim of our study was to assess the impact of HT by route of estrogen administration on the risk of recurrent VTE. A total of 1,023 consecutive postmenopausal women aged 45 to 70 years with a confirmed first VTE were recruited from an outpatient clinic of a hemostasis hospital unit between January 2000 and December 2008 and were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly